Intravenous human immunoglobulin (pH4) (Shanghai Xinxing )
静注人免疫球蛋白 (pH4)（上海新兴医药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameIntravenous human immunoglobulin (pH4) (Shanghai Xinxing )
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2001/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Xinxing Medicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Xinxing Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A